Sharescart Research Club logo
Apollo Green 72 (28.6%)ASK Investment 895 (-3.2%)AVPL 49 (0%)Bootes Impex 775 (-8.8%)CIAL 442 (-0.5%)CSK 254 (-3.1%)ESDS Software 478 (2.8%)Garuda Aerospace 468 (-2.1%)Goodluck Defence 385 (16%)Hero Motors 325 (0%)Hinduja Leyland 248 (0%)ICL Fincorp 25 (0%)Incred Holdings 154 (2.7%)Kineco Limited 3285 (0%)Lava 60 (15.4%)Market Simplified 26 (-7.1%)Matrix Gas 12 (-20%)Motilal Oswal 12.25 (-2%)MSEI 6.35 (-2.3%)NCDEX 368 (-1.6%)NSE 1985 (-2%)Onix Renewable 68 (21.4%)OYO 23 (-4.2%)OYO Assets 9.25 (-7%)Philips India 1250 (0%)Polymatech Electronics 56 (-3.4%)SBI Mutual 768 (-0.9%)Taparia Tools 6050 (0%)VCI Chemical 64 (0%)Zepto 40 (-4.8%)

15 Days Price Change

Star Imaging & Path IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size 50.95 Cr
Profile
Price Range 135  to  142 per share
Profile
Min Investment ₹142
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

The company operates a diagnostic testing network, NABL accredited, delivering pathology, radiology, Cardiology, and Neurology services in Delhi (B2C, B2B & B2G model), Uttar Pradesh (B2G model), and Nasik (B2G Model) regions of India. Read More

Basic Info

Face Value 10 per share

Price 135  to  142 per share

P/E (x) 12

Sales( Cr.) 84

PAT( Cr.) 16

EPS 11.8

Draft Prospectus

Exchange BSE-SME

Promoter

Company Promoters

Pawan Gupta Chhaya Gupta

Pre Issue Share Holding 100%

Post Issue Share Holding 71.92%

Listing Details:

Listing Price: 142

Listing Gain: 0%

Current Price: 72.9

Gain On Issue: 72.9 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Aug 08, 2025
Closing Date Aug 12, 2025
Allotment Aug 13, 2025
Refund Aug 14, 2025
Delivery of Shares Aug 14, 2025
Listing Date Aug 15, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 2000 284,000
Retail (Max) -- -- --
S-HNI (Min) 1 2000 284,000
S-HNI (Max) 3 6000 852,000
B-HNI (Min) 4 8000 1,136,000

Objective of the Issue

1. To Meet Working Capital Requirement 2. Repayment/prepayment of certain borrowings availed of by our Company 3. Funding the Capital Expenditure towards purchase of Refurbished Medical Equipment in running facilities 4. General Corporate Expenses

Issue

Category Nos Bid Bid (x)
QIB 871000 11188000 12.8x
NII 1137000 3358000 3x
Retail 1528000 3532000 2.3x
EMP 52000 16000 0.3x
Total 3588000 18094000 5x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Star Imaging & Path Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 69 59 79 84
Other Income 0 0 1 0
Total Income 69 59 80 84
Total Expenditure 54 52 56 55
Operating Profit 15 6 24 29
Interest 2 2 2 3
Depreciation 4 3 5 5
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 9 1 16 21
Provision for Tax 3 0 4 5
Profit After Tax 6 1 12 16
Adjustments -0 -0 -0 -0
Profit After Adjustments 6 1 12 16
Adjusted Earnings Per Share 4.7 0.4 9.2 11.8

Star Imaging & Path Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 18 19 31 47
Minority's Interest 0 0 0 0
Borrowings 17 14 16 15
Other Non-Current Liabilities 2 2 2 2
Total Current Liabilities 21 26 33 34
Total Liabilities 58 61 82 98
Fixed Assets 15 13 22 21
Other Non-Current Assets 12 22 7 10
Total Current Assets 32 26 53 67
Total Assets 58 61 82 98

Star Imaging & Path Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 6 9 2 16
Cash Flow from Operating Activities 14 5 18 -6
Cash Flow from Investing Activities -4 -7 -7 -4
Cash Flow from Financing Activities -7 -5 2 -0
Net Cash Inflow / Outflow 3 -7 13 -10
Closing Cash & Cash Equivalent 9 2 16 5

Star Imaging & Path Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 4.66 0.43 9.2 11.8
CEPS(Rs) 7.27 2.91 13.11 15.49
DPS(Rs) 0 0 0 0
Book NAV/Share(Rs) 13.6 14.03 23.22 34.93
Core EBITDA Margin(%) 21.24 10.32 28.73 34.31
EBIT Margin(%) 16.4 4.87 23.59 28.72
Pre Tax Margin(%) 13.59 1.52 20.46 25.67
PAT Margin (%) 9.11 1 15.81 19.11
Cash Profit Margin (%) 14.21 6.71 22.46 25.05
ROA(%) 10.79 0.98 17.43 17.75
ROE(%) 34.28 3.13 49.53 40.65
ROCE(%) 23.64 6.1 34.58 33.81
Receivable days 85.39 105.29 116.4 182.27
Inventory Days 0.4 2.21 2.69 1.68
Payable days 130.08 364.68 504.94 547.66
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.32 0.44 0.21 0.49
EV/Core EBITDA(x) 1.48 4.15 0.69 1.41
Net Sales Growth(%) 0 -15.28 34.6 5.99
EBIT Growth(%) 0 -74.86 552.4 29.06
PAT Growth(%) 0 -90.74 2036.52 28.12
EPS Growth(%) 0 -90.8 2045.1 28.26
Debt/Equity(x) 1.61 1.4 0.98 0.69
Current Ratio(x) 1.48 1.01 1.63 1.97
Quick Ratio(x) 1.48 0.98 1.61 1.96
Interest Cover(x) 5.83 1.45 7.54 9.4
Total Debt/Mcap(x) 0 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 6% 7% 0% 0%
Operating Profit CAGR 21% 25% 0% 0%
PAT CAGR 33% 39% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 41% 31% 32% 32%
ROCE Average 34% 25% 25% 25%

Company Contact Information

Star Imaging and Path Lab Ltd.

Md Shadab Khan

+91 9990019189

cs@starimaging.in

4 B/4, Tilak Nagar, Near Sant Pura Tilak Nagar West Delhi

IPO Lead Manager(s)

Star Imaging and Path Lab Ltd.

Share India Capital Services Pvt Ltd.

Registrar Info

Star Imaging and Path Lab Ltd.

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District, Nanakramguda Hyderabad – 500032 Tel. No. 040 67161500 Fax. No. 040 23001153 E-mail: einward.ris@karvy.com Website: www.karvy.com Toll Free No. of exclusive Call Centre:1-800-345001

040 - 67162222/18003094001

einward.ris@kfintech.com

https://www.kfintech.com

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp